Q26255 AF NFT

Trifunctional purine biosynthetic protein adenosine-3

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiaxlsdhp3bud7p6vmmrk76ivx4q5frckwgby5mxlmmzrei3b34o44/metadata.json
IPFS of structure file: 
bafybeif73wuymrwn6o3hqhzgdubet3vi7upomdotxyurs3r4s4encuih3q/AF-Q26255-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xEfa66a179B0bfB1956708792b71f4aa3D23c60e2
First NFT owner address (bech32): 
genesis1a7nx59ump0a3j4nss7ftw86250frcc8z5clpea
Current NFT ID #320472 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
320472
Accession (UniProt):
Q26255
Name::
Trifunctional purine biosynthetic protein adenosine-3
Experimental Method:
Predicted structure
Sequence source:
Chironomus tentans

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q26255 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q26255|PUR2_CHITE Trifunctional purine biosynthetic protein adenosine-3 OS=Chironomus tentans OX=7153 GN=GART PE=3 SV=1 MTGKKLLLIGSGGREHALAWKLQQSKNVTEIFAFPGSIGISQLEKVQLVNNNEMNLKDFKGIASWCKINHIDLVIVGPEDPLAEGIADQLKAANIHCFGPSKAGARIESDKSWSKDFMIRHHIPTAQYGSFIDALKAKDFIRNTPNALVVKASGLAAGKGVIVAENIEEACAAVDEILGDHKFGTAGDVVVVEEKLSGQEVSVLGFVDSNSVRILPPAQDHKRLKDNDEGLNTGGMGAYCPCPLISQQELDIVKSQVLQRAVDGLRKENILYNGILYAGIMLTHDGPKTLEFNCRFGDPETQIILPLLDEDLYDLMMASCTNHLCNVPELKFKSNINAVGVVMASKGYPETSTKGCVISGIESVETMDNHIVFHSGTSKNNKDEWITNGGRVLINIALADNLKKAADLATKACDVVKFDGSQYRRDIGKKAFQIHSLTYKESGVNIEAGNSLVGRIKSLSYGTHRSGVVGQIGSFGGLMRLNDIKYINSNGEESNYKDIVLVQGTDGVGTKLKIAESMNVWDTIGIDLVAMCVNDVLCNGAEPIGFLDYIACGHLEVPTVATIVKGIADGCRKANCALIGGETAEMPSMYGKGKYDLAGYCVGITEYDEILPKINDVHVGDVVIGLPSSGIHSNGFSLVNKIFQQTGFKLTDIAEFSDSHKSYGMEFLTPTRLYVSETLPFLRNGYVKALAHITGGGLLENIPRILPNHLSVQIDALTWKLPKVFSWLAAHGNVNANEMLRTFNCGIGMIIIMPRNDIEWETIPEARMIGSITQRDHNGPQVIVKNFKEVLHKEVTHWKKGDAETTSISYKDSGVDITAGNELVDNIKPHAKSTNRKGVIGGLGSFGGLFRINECGTKFEDPMLVLATDGVGTKLKIAQQLGKHDTVGIDLVAMCNNDILCNGAEPLTFLDYFACGKLDVNVATNVVSGIAEGCRQSDSTLLGGETAEMPGMYNPNVYDLAGFSLGVAEHEDILPKKNCLEVGDIIIGFPSNGVHSNGFSLIHKLFELTGYKWTDIAPFSAYGKTFGEEFLEPTKVYVKEISPALKTGYVKALAHITGGGLWDNIPRVLPYNLTAELDAKKINISPVFAWLSLNGNIDKLELLKTFNCGIGMIMIASKEHELEILKSLYGSRASVIGKIIPTKPHGHQVIVRHFATCFERVERLLSIPKKRVGVLISGSGSNLQALIDATKSTNMGMCSEIVFVLSNKAGIFGLERAAKANIPSTVISNKDYATREAFDVALHNELIKHNVEIICLAGFMRILTPCFVNKWKGKLLNIHPSLLPKYKGITAQKDALESGDNESGCTVHFVDENVDTGAIIVQEIVPIFENDTVESLTERIHVAEHIAFPKALRLVASGYVRLNDKCETEWA